Image by gandhiji40 via Flickr People who have been administered via IV the drug erythropoietin alfa after suffering a heart attack could allegedly be at risk for new heart problems and possible greater cardiac damage from the attack if a new study is accurate. The drug has been prescribed for people who had prior heart attacks patients because certain studies suggested it might reduce the extent of heart attack damage.
Find the report here:
http://jama.ama-assn.org/content/305/18/1863.short
